A Phase 1, Multicenter, Single-arm, Dose-escalation Study of CC-97540 (BMS-986353), CD19-Targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, Evaluating Safety and Tolerability in Participants with Relapsing Forms of Multiple Sclerosis (RMS) or Progressive Forms of Multiple Sclerosis (PMS)

Is this Study for You?

Let's Get Started!




Brain Imaging Center - BIC
Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Photograph of Amanda Piquet

Amanda Piquet

Study ID

Protocol Number: 23-1992

More information available at ClinicalTrials.gov: NCT06220201

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers